Results 251 to 260 of about 28,422 (269)

Omalizumab

Drugs of the Future, 2002
null Cullell-Young, M., null Bayes, M., null Leeson, P.A.   +2 more
openaire   +1 more source

The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change

Allergy: European Journal of Allergy and Clinical Immunology, 2018
Ragip Ertaş, Mustafa Atasoy, Tomasz Hawro   +2 more
exaly  

Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma

American Journal of Respiratory and Critical Care Medicine, 2017
William W Busse, Stephen J Teach, Jeremy Wildfire   +2 more
exaly  

Omalizumab and the risk of malignancy: Results from a pooled analysis

Journal of Allergy and Clinical Immunology, 2012
William W Busse, Janice Canvin
exaly  

Safety and tolerability of omalizumab

Clinical and Experimental Allergy, 2009
Thomas B Casale
exaly  

Omalizumab

Reactions Weekly, 2022
openaire   +2 more sources

Omalizumab

Reactions Weekly, 2009
openaire   +1 more source

Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma

Allergy: European Journal of Allergy and Clinical Immunology, 2011
Jean Bousquet, Marc Humbert, Klaus F Rabe   +2 more
exaly  

Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils☆

Journal of Allergy and Clinical Immunology, 2004
Henry C Lin, Calman Prussin, Thomas B Casale   +2 more
exaly  

Effectiveness of omalizumab (Xolair®) in the first patients treated in real-life practice in France

Respiratory Medicine, 2008
Mathieu Molimard, Frédéric De Blay, Alain Didier   +2 more
exaly